7/28/2023 0 Comments Project on government oversight![]() Charles Carignan, MDĪmy Kruse, PhD, is an internationally recognized, award-winning thought leader for strategic business development focused on improving human health and performance through application of neuroscience and technology with over 15 years of experience in R&D, innovation, and funding cutting-edge science. Membership on this committee may be supplemented with ad hoc participation of individuals with expertise appropriate for specific programmatic matters within the BPMT program. Based on their deep understanding of the medical device technology development process, the members provide feedback on NIH plans for project progression based on developing suitable milestones and monitoring project plans and milestone progression for individual teams and the BPMT program.Īs a link to the neurotherapeutic medical device development research community, the EOC will help the BPMT program adjust to changing landscapes to continue to provide a unique community scientific resource. They have executive-level expertise in therapeutic and diagnostic medical devices development experience, with experience in portfolio-level decision making in both academia and industry.Īs individuals, the EOC members provide their perspectives independently on the oversight, strategy, and implementation of the BPMT program, including strategies for overall portfolio management, developing and improving the program, and addressing problems as they arise. ![]() ![]() The members of the Blueprint MedTech (BPMT) External Oversight Committee (EOC) are an external advisory group of industry, clinical, regulatory, non-profit, insurance and academic experts in device development and translation directed to provide independent advice to the NIH program staff and scientific and strategic inputs for its current projects.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |